MA49148A - Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation - Google Patents

Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation

Info

Publication number
MA49148A
MA49148A MA049148A MA49148A MA49148A MA 49148 A MA49148 A MA 49148A MA 049148 A MA049148 A MA 049148A MA 49148 A MA49148 A MA 49148A MA 49148 A MA49148 A MA 49148A
Authority
MA
Morocco
Prior art keywords
dgla
acid
pharmaceutical compositions
compositions consisting
pharmaceutical
Prior art date
Application number
MA049148A
Other languages
English (en)
Inventor
John Climax
David Coughlan
Mehar Manku
Original Assignee
Ds Biopharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ds Biopharma Ltd filed Critical Ds Biopharma Ltd
Publication of MA49148A publication Critical patent/MA49148A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA049148A 2017-05-19 2018-05-17 Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation MA49148A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762508818P 2017-05-19 2017-05-19

Publications (1)

Publication Number Publication Date
MA49148A true MA49148A (fr) 2020-03-25

Family

ID=62791771

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049148A MA49148A (fr) 2017-05-19 2018-05-17 Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation

Country Status (6)

Country Link
US (1) US20180333382A1 (fr)
EP (1) EP3624787A1 (fr)
JP (1) JP2020520938A (fr)
CN (1) CN110996937A (fr)
MA (1) MA49148A (fr)
WO (1) WO2018211325A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240018593A1 (en) * 2020-11-30 2024-01-18 Kao Corporation Method for detecting severity of atopic dermatitis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006085687A1 (fr) * 2005-02-14 2006-08-17 Suntory Limited Préparation contenant de l'acide dihomo-ϝ-linolénique (dgla) au titre de principe actif
JP5546087B2 (ja) * 2005-02-14 2014-07-09 サントリーホールディングス株式会社 皮膚疾患経口治療または予防剤
US7485323B2 (en) 2005-05-31 2009-02-03 Gelita Ag Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
RU2714323C2 (ru) * 2014-06-04 2020-02-14 ДиЭс БАЙОФАРМА ЛИМИТЕД Фармацевтические композиции, содержащие дглк, и их применение
WO2017118911A1 (fr) * 2016-01-07 2017-07-13 Dignity Sciences Limited Compositions pharmaceutiques comprenant de dgla et leur utilisation

Also Published As

Publication number Publication date
JP2020520938A (ja) 2020-07-16
US20180333382A1 (en) 2018-11-22
CN110996937A (zh) 2020-04-10
EP3624787A1 (fr) 2020-03-25
WO2018211325A1 (fr) 2018-11-22

Similar Documents

Publication Publication Date Title
EP3630145A4 (fr) Compositions pharmaceutiques comprenant du cannabidiol et du bêta-caryophyllène et leurs procédés d'utilisation
EP3924481A4 (fr) Compositions et méthodes de traitement d'hémoglobinopathies
MA52644A (fr) Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation
MA52257A (fr) Compositions pharmaceutiques comprenant blautia et leur administration orale
EP3548000A4 (fr) Compositions pharmaceutiques d'atropine
EP3717636A4 (fr) Variants de capsides de virus adéno-associé et leurs procédés d'utilisation
EP3715448A4 (fr) Nouvelles bactéries d'acide lactique et leur utilisation
EP3618871A4 (fr) Formulations d'anticorps anti-lag3 etco-formulations d'anticorps anti-lag3 et d'anticorps anti-pd-1
MA43709A (fr) Composition pharmaceutique comprenant de l'empagliflozine et ses utilisations
MA47688A (fr) Compositions utiles dans le traitement de l'amyotrophie spinale
EP3880688A4 (fr) Préparations et compositions d'oligosaccharides
EP3310343A4 (fr) Compositions implantables pour administration de médicaments et méthodes d'utilisation desdites compositions
EP3380525A4 (fr) Formulations pharmaceutiques et leurs procédés d'utilisation
EP3518971A4 (fr) Formulations thérapeutiques d'anticorps et de protéines et leurs utilisations
MA46044A (fr) Compositions de nettoyage comprenant un acide aminé et leurs procédés d'utilisation
MA48461A (fr) Excipients pour réduire la viscosité de formulations d'anticorps et compositions de formulation
EP3334719A4 (fr) Benzimidazoles substitués, préparation et utilisation de ceux-ci en tant qu'agents pharmaceutiques
MA43361A (fr) Composition pour le soin et la protection de cultures
MA55015A (fr) Formulations pharmaceutiques
MA41326A (fr) Formulations pharmaceutiques comprenant du cangrelor de haute pureté et leurs procédés de préparation et d'utilisation
EP3452441A4 (fr) Dérivés d'acide alpha-truxillique et compositions pharmaceutiques associées
EP3373907A4 (fr) Compositions pharmaceutiques à libération prolongée et méthodes d'utilisation
EP3664797A4 (fr) Ligands de nr4a1, compositions pharmaceutiques et procédés d'utilisation associés
EP3402510A4 (fr) Compositions et formulations comprenant le cabazitaxel et de l'albumine sérique humaine
EP3741376A4 (fr) Probiotiques pour inhiber et prévenir l'évolution de maladies rénales et compositions pour inhiber et prévenir l'évolution de maladies rénales les comprenant